Pharmacology 7: NSAIDs and Narcotic Analgesics Flashcards
What are most established NSAIDs derived from?
carboxylic acid
main therapeutic effects of NSAIDs?
analgesia
anti-inflammation
anti-pyresis
primary mode of action of NSAIDs?
competitive inhibition of COX which converts arachidonic acid= produced through cleavage of membrane phospholipids, to eicosanoids e.g. prostanoids- PGs, prostacyclins and thromboxanes.
inhibition occurs as sit within COX-1 and 2, so compete with arachidonic acid for binding
blocking which enzyme seems responsible for most NSAID ADRs?
COX-1
which enzyme is considered the site for NSAIDs exerting their therapeutic anti-inflammatory/analgesic effect?
COX-2= induced in inflammatory cells following activation by cytokines.
how does aspirin differ from the other NSAIDs in terms of its action on COX?
aspirin irreversibly inhibits COX enzymes by acetylation= covalent, which allows it to inhibit platelet aggregation through inhibition of COX-1 which inhibits thromboxane A2 production.
other NSAIDs reversibly inhibit COX
describe how NSAIDs exert an ANALGESIC effect
inhibit COX-2, reducing PG synthesis hence reducing the senstitisation of nociceptors to inflammtory mediators- both peripherally and centrrally.
reduces headache pain as inhibits cerebral vasodilation mediated by PGs
May also have secondary effect on PG facilitation of afferent pain signal in SC dorsal horn neurones- central sensitisation-inhinit PGE2 acting on secondary nociceptive neurones in dorsal horn which would increase perception of pain.
what do NSAIDs primarily reduce with respect to their anti-inflammtory action?
erythema, swelling and pain response assoc. with swelling through inhibition of COX-2 and hence PG prod.
how do NSAIDs exert their antipyresis function?
inhibition of PG-E2 production, which is produced by the hypothalamus following the release of endogenous pyrogen IL-1 from macrophages when triggered by bacterial endotoxins, (IL-1 possibly induces COX-2 to stimulate PGE2 production?). PG-E2 elevates set point on central ‘thermostat’ of hypothalamus via EP3 receptor - Gi type GPCR, so decrease cAMP and increase Ca2+ in neurones regulating temperature causing increased heat production and reduced heat loss
what type of elimination kinetics does aspirin exhibit?
dose-dependent, so low doses= 1st order, t1/2 4hrs, whereas high dose= 0 order kinetics
ADRs of NSAIDs due to COX-1 inhibition?
gastric ulcers- haemorrhage, perforation, as inhibition of PGE2 production via COX-1 which protects gastric mucosa by increasing mucosal blood flow and stimulating alkali and mucus production which protects the mucosa from gastric acid production by parietal cells. Also stimulates cytoprotective mucus secretion throughout GI tract.
nausea, diarrhoea, GI discomfort- dyspepsia
Renal ADRs in susceptible patients- reversible reduction in GFR as PGE2 and PGI2 inhibition
hypersensitivity reactions- rashes, asthmatic bronchospasm and allergic response
prolonged bleeding time
which patients are at particular risk of GI and renal ADRs of NSAIDs?
neonates, elderly and patients with compromised Renal, Hepatic- increased risk of GI bleeding and fluid retention, and Cardiac function- NSAIDs may impair renal function- inhibit PG production which dilates renal afferent arteriole, or reduced blood volume
ADRs of selective COX-2 inhibitors?
Diclofenac and the selective inhibitors of cyclo-oxygenase-2 (celecoxib, etoricoxib, and parecoxib) are contra-indicated in ischaemic heart disease, cerebrovascular disease, peripheral arterial disease, and mild to severe heart failure.
COX-2 selective inhibitors, diclofenac (150 mg daily) and ibuprofen (2.4 g daily) are associated with an increased risk of thrombotic events.
Selective inhibitors of COX-2 are associated with a lower risk of serious upper gastro-intestinal side-effects than non-selective NSAIDs
selective COX-2 assoc with increased risk of hypertension, cardiac and renal failure
important DDIs of NSAIDs and aspirin with non-NSAID drugs
with corticosteroids: corticosteroids may increase incidence and/or severity of ulceration assoc. with NSAIDs, increasing possibility of GI bleeding
aspirin and warfarin- aspirin displaces warfarin for plasma protein binding sites as aspirin=class II drug, so warfarin= higher free plasma concentration, more at risk of toxic SEs= higher bleeding risk, AND both affect platelet aggregation= PDs
NSAIDs and ACEIs- NSAIDs can attenuate their action by blocking prod. of vasodilating PGs, so may massively reduced GFR
with sulfonylureas- increase risk of hypoglycameia
with methotrexate- increase risk of MTX ADRs
what monitoring is required for patients on chronic NSAID therapy?
regular review of GI symptoms
monitor renal function
why might aspirin be useful in GI cancer prophylaxis?
inhibits PGE2 production which is synthesised by cancers in colon, rectum and possibly upper GI, and this PGE2 promotes tumour growth
may also be prophylactic in breast cancer and other cancers.
1st agent of choice for mild to moderate cases of pain or fever?
paracetemol
how does paracetemol appear to have an analgesic and antipyretic property?
Currently unknown mechanism – weak COX-1 / COX-
2 inhibitor.Considered to primarily act in CNS possibly on a COX-3 isoform and one of its metabolites in CNS can combine with arachidonic acid to form a substrate that inhibits COX-1 and -2 activity.
within what time period should a paracetemol OD be ideally treated and with what?
within 8 hours
IV N-acetylcysteine- but this can protect the liver if infused up, and possibly beyond, 24 hrs of paracetemol ingestion
oral methionine= both increase hepatic glutathione levels
after what time period is a patient likely to die of liver failure following paracetemol OD?
after 48 hours
what damaging conditions may occur secondarily to paracetemol OD?
renal tubular necrosis
hypoglycaemic coma
what may be monitored in patients on LT paracetemol?
hepatic and renal function
where are endogenous opioids found in body?
specific parts of CNS and PNS: limbic system, thalamus, SC, primary afferent peripheral terminals
3 major groups of endogenous opioids?
enkephalins
endorphins e.g. beta-endorphin from POMC
dynorphins e.g. dynorphin
how is the period of effective analgesia extended with morphine?
one of its metabolic products= morphine-6-glucuronide is at least pharmacologically equivalent to morphine with t1/2=4-5hrs
slow release oral morphine preps used in chronic pain control
what effect do opiates have that is responsible for resp depression?
mu receptor mediated action on CO2 sensitivity
opioid ADRs?
resp depression- action on mu receptors in brainstem
euphoria
confusion
miosis- constricted pupil
psychosis
dependance
tolerance
drowsiness- due to central effect on brain (sedatory effect?)
coma
nausea- mu receptors in brainstem
vomiting-direct stimulatory effect on vomiting centre in brain so may need to also prescribe an anti-emetic
constipation- espec. codeine- given orally
hypotension
what enzyme allows conversion of membrane phospholipids to arachidonic acid?
phospholipase A2
why are most NSAID ADRs mediated by inhibiton of COX-1?
constitutive expression of COX-1, found in wide range of tissue types
PG synthesis via this enzyme has major cytoprotective role= gastric mucosa, myocardium and renal parenchyma as ensures optimised local perfusion-reduces ischaemia
how do PGs contribute to increased vascular permeability?
don’t do so directly, but synergise actions of bradykinin and histamine
typical dosing route for NSAIDs?
oral
but many topical applications for soft tissue injury
key factor in pharmacokinetics of NSAIDs in terms of drug distribution?
mainy heavily bound to plasma proteins- 90-99%
*importance with DDIs, if displace drugs from their protein binding sites then increase free plasma conc and so can increase risk of drug toxicity
what can be given to patients to offset GI ADRs in the LT with NSAID therapy?
PPIs e.g. lansoprazole, omeprazole
misoprostol- synthetic PGE1 analogue
why do ADRs commonly occur with combination NSAIDs?
patients self-medicating with NSAIDs e.g. ibuprofen, and then receiving prescribed NSAIDs, PD DDI
examples of highly protein bound drugs affected by NSAIDs?
sulphonylureas e.g. gliclazide
warfarin
methotrexate
what is aspirin rapidly hydrolysed to in plasma?
salicylate